"Always trendy". Neoclassic, or favorite endometriosis localizations

Endometriosis continues to be an unsolved/unsolvable problem of modern gynecology. There are only 3 most common clinical phenotypes of this disorder: superficial peritoneal endometriosis, cystic ovarian endometriosis and deeply infiltrative endometriosis. In view of significantly reduced quality of life in patients with endometriosis resulting from algological symptoms and endometriosis-associated infertility, it is necessary to consider the features of clinical management of a patient with the “favorite” endometriosis localization to provide effective clinical management and improve the therapy efficacy. Key words: endometriosis, superficial peritoneal endometriosis, cystic ovarian endometriosis, deeply infiltrative endometriosis, surgical treatment, dienogest, coc. Key words: endometriosis, superficial peritoneal endometriosis, cystic ovarian endometriosis, deeply infiltrative endometriosis, surgical treatment, dienogest, coc. About the Author Mekan R. Orazov 1 , Viktor E. Radzinskii 1 , Evgenii D. Dolgov 11 Patrice Lumumba Peoples' Friendship University of Russia, Moscow, Russia

1. Yilmaz BD, Bulun SE. Endometriosis and nuclear receptors. Hum Reprod Upd 2019; 25 (4): 473–85. 2. Anastasiu CV, Moga MA, Elena Neculau A et al. Biomarkers for the Noninvasive Diagnosis of Endometriosis: State of the Art and Future Perspectives. Int J Mol Sci 2020; 21: 1750. DOI: 10.3390/ijms21051750 3. Parazzini F, Esposito G, Tozzi L et al. Epidemiology of endometriosis and its comorbidities. Eur J Obstet Gynecol Reprod Biol 2017; 209: 3–7. 4. Cardoso JV, Machado DE, Silva MCD et al. Epidemiological profile of women with endometriosis: a retrospective descriptive study. Revista Brasileira de Saúde Materno Infantil. 2021; 20: 1057–67. 5. Benagiano G, Brosens I, Lippi D. The history of endometriosis. Gynecol Obstet Investig 2014; 78: 1–9. 6. Florova MS, Yarmolinskaya MI, Potin VV. Prospects of metformin in the treatment of endometriosis. J Obstet Women's Dis 2017; 66 (2). 7. Dunselman GA, Vermeulen N, Becker C et al. ESHRE guideline: Management of women with endometriosis. Hum Reprod 2014; 29: 400–12. 8. Федеральные клинические рекомендации «Эндометриоз». 2020. Federal clinical guidelines "Endometriosis". 2020 (in Russian). 9. Muzii L, Di Tucci C, Di Feliciantonio M et al. Management of endometriomas. Semin Reprod Med 2017; 35 (1): 25–30. DOI:10.1055/s-0036-1597126 10. Hoyle AT, Puckett Y. Endometrioma. StatPearls [Internet]. StatPearls Publishing, 2021. 11. Stern JE, Luke B, Tobias M et al. Adverse pregnancy and birth outcomes associated with underlying diagnosis with and without assisted reproductive technology treatment. Fertil Steril 2015; 103: 1438–45. 12. Cohen J, Ziyyat A, Naoura I et al. Effect of induced peritoneal endometriosis on oocyte and embryo quality in a mouse model. J Assist Reprod Genet 2015; 32: 263–70. 13. Piriyev E, Schiermeier S, Römer T. Coexistence of endometriomas with extraovarian endometriosis and adhesions. Eur J Obstet Gynecol Reprod Biol 2021; 263: 20–4. 14. Yılmaz Hanege B, Güler Çekıç S, Ata B. Endometrioma and ovarian reserve: effects of endometriomata per se and its surgical treatment on the ovarian reserve. Facts Views Vis Obgyn 2019; 11 (2): 151–7. 15. Johnson NP, Hummelshoj L, World Endometriosis Society Montpellier Consortium. Consensus on current management of endometriosis. Hum Reprod 2013; 28: 1552–68. 16. Horne AW, Daniels J, Hummelshoj L et al. Surgical removal of superficial peritoneal endometriosis for managing women with chronic pelvic pain: time for a rethink? BJOG 2019; 126 (12): 1414. 17. Nisolle M, Donnez J. Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities. Fertil Steril 1997; 68 (4): 585–96. 18. Koninckx PR, Ussia A, Adamyan LV et al. Deep endometriosis: definition, diagnosis, and treatment. Fertil Steril 2012; 98 (3): 564–71. 19. Tosti C, Pinzauti S, Santulli P et al. Pathogenetic mechanism of deep infiltrating endometriosis. Reprod Sci 2015; 22 (9): 1053–9. 20. Gargett CE, Schwab KE, Brosens JJ et al. Potential role of endometrial stem/progenitor cells in the pathogenesis of early-onset endometriosis. Mol Hum Reprod 2014; 20 (7): 591–8. 21. Machado DE, Abrao MS, Berardo PT et al. Vascular density and distribution of vascular endothelial growth actor (VEGF) and its receptor VEGFR-2 (Flk-1) are significantly higher in patients with deeply infiltrating endometriosis affecting the rectum. Fertil Steril 2008; 90 (1): 148–55. 22. Русина Е.И., Ярмолинская М.И., Пьянкова В.О. Глубокий инфильтративный эндометриоз. Спорные вопросы: за и против. Гинекология. 2020; 5. Rusina E.I., Yarmolinskaya M.I., Pyankova V.O. Deep infiltrative endometriosis. Controversial issues: pros and cons. Gynecology. 2020; 5 (in Russian). 23. Quintana RL. Endometriosis infiltrativa profunda en la vejiga, resección quirúrgica por laparoscopia. Reporte de un caso y revisión de la bibliografía. Revista Mexicana De Medicina De La Reproducción 2022; 13 (d). 24. Kor E et al. Relationship between the severity of endometriosis symptoms (dyspareunia, dysmenorrhea and chronic pelvic pain) and the spread of the disease on ultrasound. BMC Res Notes 2020; 13: 1–8. 25. Gete DG, Doust J, Mortlock S et al. Associations between endometriosis and common symptoms: findings from the Australian Longitudinal Study on Women’s Health. Am J Obstet Gynecol 2023. 26. Missmer SA, Hankinson SE, Spiegelman D et al. Incidence of laparoscopically confirmed endometriosis by demographic, anthropometric, and lifestyle factors. Am J Epidemiol 2004; 160: 784–96. 27. Agarwal SK, Chapron C, Giudice LC et al. Clinical diagnosis of endometriosis: A call to action. Am J Obstet Gynecol 2019; 220: 354.e1–354.e12. 28. Guideline of European Society of Human Reproduction and Embryology. Endometriosis. 2022. 29. Vercellini P, Viganò P, Buggio L, Somigliana E. We Can Work It Out: The hundred years' war between experts of surgical and medical treatment for symptomatic deep endometriosis. J Minim Invasive Gynecol 2018; 25 (3): 356–9. 30. Jiang D, Nie X. Effect of endometrioma and its surgical excision on fertility (Review). Exp Ther Med 2020; 20 (5): 114. DOI: 10.3892/etm.2020.9242. Epub 2020 Sep 18. PMID: 32989392; PMCID: PMC7517518. 31. Kim HJ et al. Dienogest May Reduce Estradiol-and Inflammatory Cytokine-Induced Cell Viability and Proliferation and Inhibit the Pathogenesis of Endometriosis: A Cell Culture-and Mouse Model-Based Study. Biomedicines 2022; 10 (11): 2992. 32. Zakhari A et al. Dienogest and the risk of endometriosis recurrence following surgery: a systematic review and meta-analysis. J Min Invasive Gynecol 2020; 27 (7): 1503–10. 33. Оразов М.Р., Радзинский В.Е., Орехов Р.Е. Эффективность терапии эндометриоз-ассоциированной тазовой боли, резистентной к хирургическому лечению. Гинекология. 2021; 23 (4): 314–23. DOI: 10.26442/20795696.2021.4.201097 Orazov M.R., Radzinsky V.E., Orekhov R.E. Efficiency of therapy for endometriosis-associated pelvic pain resistant to surgical treatment. Gynecology. 2021; 23 (4): 314–23. DOI: 10.26442/20795696. 2021.4.201097 (in Russian). 34. Shamran S. Evaluation of the effect of using NSAIDs on ovulation in women during reproductive age: a case control study. Al-Qadisiyah Med J 2019; 15 (1): 109–12. 35. Оразов М.Р., Раевская О.А., Москвичева В.С. Перебирая фолианты. Ведение больных эндометриозом: обновленный гайд-лайн ESHRE (2022). Информационный бюллетень. Под ред. В.Е. Радзинского. М.: Редакция журнала StatusPraesens, 2022. Orazov M.R., Raevskaya O.A., Moskvicheva V.S. Going through the volumes. Management of endometriosis: updated ESHRE guideline (2022). News bulletin. Ed. V.E. Radzinsky. M.: Editorial office of the magazine StatusPraesens, 2022. (in Russian). 36. Тихомиров А.Л. Триггеры и профилактика эндометриоза. Трудный пациент. 2019; 17 (8-9): 13–9. 37. Laganà AS et al. The pathogenesis of endometriosis: molecular and cell biology insights. Int J Mol Sci 2019; 20 (22): 5615. 38. Han SJ, Lee JE, Cho YJ et al. Genomic Function o f Estrogen Receptor β in Endometriosis. Endocrinology 2019; 160: 2495–516. 39. Fukui A et al. Pelvic endometriosis and natural killer cell immunity. Am J Reprod Immunol 2021; 85 (4): e13342. 40. Melioli G, Semino C, Semino A et al. Recombinant interleukin-2 corrects in vitro the immunological defect of endometriosis. Am J Reprod Immunol 1993; 30 (4): 218–27. DOI: 10.1111/j.1600-0897.1993.tb00623 41. Smolarz B, Szyłło K, Romanowicz H. Endometriosis: epidemiology, classification, pathogenesis, treatment and genetics (review of literature). Int J Mol Sci 2021; 22 (19): 10554. 42. Nisolle M, Donnez J. Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities. Fertil Steril 1997; 68: 585–96. 43. Becker CM, Bokor A, Heikinheimo O et al. ESHRE guideline: Endometriosis. Hum Reprod Open 2022; 26. 44. Оразов М.Р., Радзинский В.Е., Орехов Р.Е., Таирова М.Б. Эффективность профилактики рецидивов после хирургического лечения эндометриоза яичников. Вопросы гинекологии, акушерства и перинатологии. 2022; 21 (3): 53. Orazov M.R., Radzinsky V.E., Orekhov R.E., Tairova M.B. Efficiency of relapse prevention after surgical treatment of ovarian endometriosis. Issues of gynecology, obstetrics and perinatology. 2022; 21 (3): 53. (in Russian). 45. Оразов М.Р., Долгов Е.Д. Профилактика рецидивов эндометриоза: сказки братьев Гримм или суровая реальность в классическом бальзаковском жанре. Women’s Clinic. 2022; 4: 57–65. Orazov M.R., Dolgov E.D. Prevention of relapse of endometriosis: fairy tales of the Brothers Grimm or harsh reality in the classical Balzac genre. Women's Clinic. 2022; 4: 57–65 (in Russian). 46. Давыдов А.И., Михалева Л.М., Хабарова М.Б. и др. Эндометриоидная цистаденома – глубокий яичниковый эндометриоз. Вопросы гинекологии, акушерства и перинатологии. 2022; 21 (3): 130–7. DOI: 10.20953/1726-1678-2022-3-130-137 Davydov A.I., Mikhaleva L.M., Khabarova M.B. and others. Endometrioid cystadenoma – deep ovarian endometriosis. Issues of gynecology, obstetrics and perinatology. 2022; 21 (3): 130–7. DOI: 10.20953/1726-1678-2022-3-130-137 (in Russian). 47. Brosens IA. Endometriosis. 48. Vercellini P, Somigliana E, Vigano P et al. ‘Blood On The Tracks’ from corpora lutea to endometriomas. 49. Donnez J, Nisolle M, Gillet N et al. Large ovarian endometriomas. 50. Nisenblat V, Bossuyt PMM, Farquhar C et al. Imaging modalities for the non-invasive diagnosis of endometriosis. Cochrane Database Syst Rev 2016; 2: CD009591. 51. Bazot M, Lafont C, Rouzier R et al. Diagnostic accuracy of physical examination, transvaginal sonography, rectal endoscopic sonography, and magnetic resonance imaging to diagnose deep infiltrating endometriosis. Fertil Steril 2009; 92: 1825–33. 52. Abrao M, Neme R, Carvalho F et al. Histological classification of endometriosis as a predictor of response to treatment. Int J Gynecol Obstet 2003; 82. 53. Estrogen Receptor α, Progesterone Receptor, and Progesterone Receptor B Proteins in Rectosigmoid Endometriosis: A Tissue Microarray Study. Reprod Sci 2014; 22: 31–7. 54. Tosti C, Pinzauti S, Santulli P et al. Pathogenetic Mechanisms of Deep Infiltrating Endometriosis. Reprod Sci 2015; 22: 1053–9. 55. Guerriero S, Saba L, Ajossa S et al. Three-dimensional ultrasonography in the diagnosis of deep endometriosis. Hum Reprod 2014; 29: 1189–98. 56. Moura APC, Ribeiro HSAA, Bernardo WM et al. Accuracy of transvaginal sonography versus magnetic resonance imaging in the diagnosis of rectosigmoid endometriosis: Systematic review and meta-analysis. PLoS ONE 2019; 14: e0214842. For citation:Orazov M.R., Radzinskii V.E., Dolgov E.D. "Always trendy".Neoclassic, or Favorite endometriosis localizations. Clinical review for general practice. 2023; 4 (9): 6–14 (In russ.). doI: 10.47407/kr2023.4.9.00323 All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.